Genmab (GMAB)
(Delayed Data from NSDQ)
$28.15 USD
+0.69 (2.51%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $28.14 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: BMO |
3/2024 | $0.16 | -10.97% |
Earnings Summary
For their last quarter, Genmab (GMAB) reported earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.34 per share. This reflects a positive earnings surprise of 5.88%. Look out for GMAB's next earnings release on May 02, 2024. For the next earning release, we expect the company to report earnings of $0.16 per share, reflecting a year-over-year increase of 220%.
Earnings History
Price & Consensus
Zacks News for GMAB
Genmab A/S Sponsored ADR (GMAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
GMAB: What are Zacks experts saying now?
Zacks Private Portfolio Services